Bristol-Myers Squibb and Amphotericin B
 

TAC/ALP campaign to get Bristol-Myers Squibb to reduce the price of amphotericin B


TAC and the AIDS Law Project (ALP) have successfully campaigned for Bristol-Myers Squibb (BMS) to reduce the price of amphotericin B to R22.60 per vial in both the private and public sectors, effective 1 July 2005. This price excludes VAT (14%) and logistical costs in the private sector (at most 10%). Below is the correspondence between the ALP and BMS which resulted in this price reduction: